| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |